In the first half of May 2025, Calcium Acetate prices in the Asian market saw a slight decline. This continues the downward trend observed in April, driven by subdued demand fundamentals, oversupplied inventories, and softening raw material costs across the region.

• Calcium Acetate prices in Asia dropped in 1st half May 2025 after same trend in April due to high inventory and weak fundamentals.
• In China, Calcium Acetate prices was under pressure as production was high while domestic and export demand was soft, with lower Acetic Acid and deflationary raw material prices.
• India Calcium Acetate market saw a big drop in April due to lower raw material cost, stronger rupee and competitive pricing from Chinese suppliers.
• Demand for Calcium Acetate was soft across Asia as buyers were cautious with high inventory and limited downstream activity in pharma and healthcare sectors.
• Calcium Acetate prices will drop slightly in 2nd half May as high production and excess inventory will intensify price competition in regional supply chain.

In April 2025, Calcium Acetate prices in China fell as the market was still oversupplied and industrial activity was slowing down. Domestic production was higher than consumption and international demand was weak, so the supply-demand imbalance continued. The official Purchasing Managers Index dropped to 49.0, indicating a contraction in the manufacturing sector and weak economy. The Acetic Acid prices also went down, a key raw material for Calcium Acetate production, so the production cost went down and the price went down further. China’s Producer Price Index was down 2.5% year on year, meaning the input cost was deflationary. Producers had no bargaining power, so they had to adjust the price to clear the inventory amid weak export demand caused by the US-China trade tensions.

Similarly, India’s Calcium Acetate market saw a price correction in April due to lower input costs and more availability. Acetic Acid prices fell, and the rupee appreciated against the dollar which helped in reducing the overall cost of production. India’s Manufacturing Purchasing Managers Index rose to a 10-month high, indicating strong industrial output which led to inventory buildup. Meanwhile Chinese exporters were pricing competitively and Indian producers had to lower their prices of Calcium Acetate to maintain market share. This created a supply led scenario and reinforced bearish trend in the domestic market.

ChemAnalyst reported on the demand side, both Chinese and Indian Calcium Acetate markets saw a decline in buying activity. In China, pharma and healthcare saw slower offtake as economic uncertainty and trade restrictions reduced demand. In India, cautious buying due to oversupply and record low inflation led to minimal restocking and weak consumer spending, which in turn weakened downstream demand. Across Asia, all these factors combined to reduce buying interest and support the soft prices.

According to market sources, Calcium Acetate prices are expected to remain low in the 2nd half of May in Asia. Regional supply chain will continue to be oversupplied as manufacturing facilities run at high capacity. This will flood the distribution channels with excess stock and intensify competitive pricing pressure across the supply chain and continue the current downward trend.